脑内肾素血管紧张素系统在帕金森病发病机制中的作用
被引量:2
摘要
肾素-血管紧张素系统(renin-angiotensin system,RAS)在参与体液水盐平衡和血压调节同时,对心脑血管疾病发生发展起重要作用。随着对脑内RAS的认识深入,诸多证据[1]确定脑内RAS与临床最常见神经变性疾病如Alzheimer病(AD)、
出处
《中华临床医师杂志(电子版)》
2012年第5期12-16,共5页
Chinese Journal of Clinicians(Electronic Edition)
二级参考文献56
-
1李卫,何新叶,张宇清.中国四个大规模抗高血压临床试验Meta分析[J].疾病控制杂志,2007,11(1):20-23. 被引量:8
-
2龚培力.抗高血压药物的评价与研究进展[J].医药导报,2007,26(4):334-339. 被引量:62
-
3Volpe M, Tocci G. Antihypertensive therapy and cerebrovascular protection[J]. Curr Opin Nephrol Hypertens, 2006,15:498.
-
4Redon J, Roca-Cusachs A, Mora-Macia J. Uncontrolled early morning blood pressure in medicated patients: the ACAMPA study. Analysis of the control of blood pressure using ambulatory blood pressure monitoring[ J ]. Blood Press Monit, 2002,7 : 111.
-
5Kario K. Time for focus on morning hypertension: pitfall of current antihypertensive medication[J].Am J Hypertens, 2005,18 : 149.
-
6Lawes CM, Bennett DA, Feigin VL,et al. Blood pressure and stroke: an overview of published reviews[ J]. Stroke,2004,35:776.
-
7Aronow WS, Frishman WH. Treatment of hypertension and prevention of ischemic stroke [ J ]. Curr Cardiol Rep, 2004,6 : 124.
-
8Turnbull F, Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of different blood-pressure-lowering regimens on major cardiovascular events : results of prospectively-designed overviews of randomised trials[ J]. Lancet, 2003,362:1527.
-
9Hackam DG. Angiotensin receptor blockers should be regarded as first-line drugs for stroke prevention in both primary and secondary prevention settings : Yes [ J ]. Stroke, 2009,40:3159.
-
10Schrader J, Kulschewski A, Dendorfer A. Inhibition of the RAS and stroke prevention[J]. Am J Cardiovasc Drugs, 2007,7:25.
共引文献11
-
1谢峰.脑血管病预防中的抗高血压治疗策略探析[J].医学信息(医学与计算机应用),2014,0(8):428-429.
-
2潘安枝.80岁以上老龄人非外伤性脑实质出血39例临床分析[J].内科,2010,5(6):592-593.
-
3陆杰,张颖冬,石静萍.血管紧张素-(1-7)对大鼠局灶性脑缺血再灌注损伤后诱导型一氧化氮合酶表达的影响[J].中华神经科杂志,2011,44(2):128-131. 被引量:4
-
4张艳,范磊.中药配合耳压法对高血压患者生活质量影响的临床研究[J].中西医结合心脑血管病杂志,2012,10(8):907-908. 被引量:6
-
5周青.社区健康教育对高血压病疗效影响的观察[J].中华全科医学,2012,10(12):1915-1916. 被引量:8
-
6窦志飞,刘喜平,施晓宇,范国峰.133例老年非房颤性脑卒中患者复发因素的临床分析[J].心脑血管病防治,2014,14(3):243-245.
-
7刘浩,苏敬敬,蔡雷,袁勇贵.脑与心脏交互作用的研究进展[J].中国临床神经科学,2018,26(6):688-695.
-
8通文丽,宋创业,李有,袁进国.中药配合综合干预对高血压病的防治效果研究[J].海南医学院学报,2014,20(11):1509-1511. 被引量:3
-
9冯耀耀,张长国,陈静,张强春,周胜华.血清肾素-血管紧张素系统与帕金森病抑郁症状的相关性[J].浙江医学,2018,40(8):878-879. 被引量:10
-
10孟庆莉,齐晓涟,孙路路.1例脑出血患者药物降压治疗的药学监护[J].中国药师,2018,21(6):1054-1057. 被引量:2
同被引文献61
-
1Mehanna R, Jankovic J. Movement disorders in cerebrovascular disease [ J ]. Lancet Neurol, 2013,12 (6) :597-608.
-
2Bansil S, Prakash N, Kaye J, et al. Movement disorders after stroke in adults: a review [ DB/OL ]. Tremor Other Hyperkinet Mov, 2012, 2. http://www, tremorjournal. org/article/view/42.
-
3Handley A, Medcalf P, Hellier K, et al. Movement disorders after stroke [ J ]. Age Ageing, 2009,38 ( 3 ) : 260 -266.
-
4Siniscalchi A, Gallelli L, Labate A, et al. Post-stroke movement disorders: clinical manifestations and pharmacological management [ J ]. Curr Neuropharmacol,2012,10 ( 3 ) : 254-262.
-
5Ghika-Schmid F, Ghika J, Regli F, et al. Hyperkinetic movement disorders during and after acute stroke: the Lausanne Stroke Registry [ J ]. J Neurol Sci, 1997, 146 (2) :109-116.
-
6Alarc6n F, Zijlmans JCM, Duefias G, et al. Post-stroke movement disorders : report of 56 patients [ J ]. J Neurol Neurosurg Psyehiat, 2004,75 ( 11 ) : 1568-1574.
-
7van Zagten M, Lodder J, Kessels F. Gait disorder and parkinsonian signs in patients with stroke related to small deep infarcts and white matter lesions [ J ]. Mov Disord, 1998,13 ( 1 ) :89-95.
-
8Fohynie T, Barker R, Brayne C. Vascular parkinsonism : a review of the precision and frequency of the diagnosis [ J ]. Neuroepidemio1,2002,21 ( 1 ) :1-7.
-
9Thanvi B, Lo N, Robinson T. Vascular parkinsonism : an important cause of parkinsonism in older people [ J ]. Age Ageing,2005,34 (2) : 114-119.
-
10Kim JS. Delayed onset mixed involuntary movements after thalamic stroke. Clinical, radiological and pathophysiological findings [ J ]. Brain, 2001,124 ( Pt 2 ) : 299-309.
引证文献2
-
1张颖冬.脑血管病相关性运动障碍的认识现状[J].中国脑血管病杂志,2014,11(2):57-63. 被引量:6
-
2赵洪锐,吴亮,田有勇,高擎,曹洁,欧洲,沙志涛,耿丛,张颖冬.血管紧张素Ⅱ对鱼藤酮诱导的多巴胺能细胞氧化应激的影响[J].南京医科大学学报(自然科学版),2015,35(6):766-771. 被引量:1
二级引证文献7
-
1张颖冬,吴亮,高擎,赵洪锐,曹洁.原发进行性冻结步态1例报告及文献复习[J].中国临床神经科学,2014,22(4):396-401. 被引量:3
-
2张颖冬.帕金森综合征中的肌张力障碍[J].临床神经病学杂志,2015,28(3):161-166. 被引量:7
-
3付强,赵敏,张倩,丁则昱,杜丽娟,王伊龙,曲辉,董可辉,陈步星,王拥军.房间隔结构异常致缺血性卒中患者的介入封堵治疗[J].首都医科大学学报,2016,37(1):48-53. 被引量:5
-
4王环宇.抑郁障碍对帕金森病患者生活质量的影响[J].中国现代神经疾病杂志,2016,16(9):633-635. 被引量:5
-
5郝帅,胡军,陈芸.烟碱对帕金森病模型小鼠多巴胺释放的影响及机制探讨[J].南京医科大学学报(自然科学版),2017,37(6):686-690. 被引量:1
-
6庄卫生,李弯月,钱宝延,蔡西国,郭真真,王恒,张莹.A型肉毒毒素注射治疗卒中后肌张力障碍的临床观察[J].中华物理医学与康复杂志,2019,41(8):579-583. 被引量:7
-
7陈罗文,杨学成,黄捷,杜淑连.依达拉奉治疗血管源性帕金森综合征的临床研究[J].中国医药科学,2020,10(2):60-62. 被引量:6
-
1KocisP,杜建红.药物化学新趋势[J].国外医学(药学分册),1995,22(5):267-271.
-
2莫云凌.抗尼古丁药物可治疗神经变性疾病[J].国外医学情报,2000,21(2):38-38.
-
32011中国老年痴呆与相关疾病学术会议[J].中华老年医学杂志,2011,30(1):12-12.
-
4李聪,朱继军.血管紧张素-(1—7)的研究进展[J].中原医刊,2008,35(6):56-57.
-
5钟毅,李家富.ANG(1-7)与高血压保护作用[J].中国心血管病研究,2008,6(9):702-705. 被引量:1
-
6雒芳玲.单硝酸异山梨酯治疗高血压急症临床观察[J].中国医药,2006,1(11):648-649. 被引量:3
-
7占伊扬,姜潇,黄峻,程蕴琳.抗高血压药物遗传学研究进展[J].中国全科医学,2007,10(4):329-331. 被引量:6
-
8张平.抗高血压药物遗传学研究进展[J].医学信息,2010,23(13):2221-2222. 被引量:1
-
9李静,王秀英,孙伟.单胺氧化酶抑制剂在神经变性疾病中的研究进展[J].首都医药,2003,10(16):17-19. 被引量:7
-
10丁江华,袁利亚,陈国安.心脏激素的抑瘤效应及作用机制[J].广东医学,2012,33(18):2856-2858. 被引量:1